This panel aids in the diagnosis and characterisation of neoplasms of hematopoietic origin. Results are useful in the differential diagnosis, therapeutic monitoring and detection of relapses of Acute leukemias which can be Acute Myeloid Leukemia (AML) or Acute Lymphoblastic leukemia (ALL). It is important to distinguish between the two as the therapy depends on the morphology.